The SynGAP Research Fund 501(c)(3) dba Cure SYNGAP1 announced a $108,867 grant to Dr. Michael Courtney and Dr. Li-Li Li at the Turku Bioscience Centre, University of Turku, Finland, to advance their research on SYNGAP1 missense variants. Their project seeks to better understand the functional impact of these mutations and explore drug repurposing as a potential therapeutic approach.

Dr. Courtney’s team will use advanced phenotyping techniques to assess how SYNGAP1 missense variants impact the protein’s interaction with key neuronal components, such as PSD95, which is crucial for synaptic function. The project will also evaluate repurposed drugs like Nortriptyline and Tanganil for their ability to restore normal protein function. This comprehensive approach could lead to new therapeutic strategies for patients with SYNGAP1-Related Disorders (SRD). >> Keep reading 

academy of finland academy professor alzheimer's disease Awards BioCity Turku bioinformatics breast cancer cancer Chancellor’s Prize for young researchers christmas computationl tools defence discoveries discovery dissertation Duodecim Elias Tillandz ffgc funding funding news Global Young Scientist Summit grant grants group leader immunology introduction MALDI Imaging Mass Spectrometry metabolomics multimedia science Nature Communications nominations novo nordisk foundation rector research results reserach results science sequencing Sigrid Jusélius spatial omics The European Research Council The Finnish Cultural Foundation vacancy Åbo Akademi